Non-metastatic Pancreatic Cancer: Resectable, Borderline Resectable, and Locally Advanced-Definitions of Increasing Importance for the Optimal Delivery of Multimodality Therapy
Douglas B. Evans(The University of Texas MD Anderson Cancer Center), Susan Tsai(The Ohio State University Wexner Medical Center), Ben George(Medical College of Wisconsin)
Cited by 87
Related Papers
Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models
|BMC Cancer|2018|391
Population-Based Study of Islet Cell Carcinoma
|Annals of Surgical Oncology|2007|338
Plasma extracellular RNA profiles in healthy and cancer patients
|Scientific Reports|2016|294
Circulating giant macrophages as a potential biomarker of solid tumors
|Proceedings of the National Academy of Sciences|2014|281